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Background: Cause for gastroenteritis range from viral, bacterial to parasitic pathogens. Rapid Multiplexing
techniques like ProGastro_SSCS and xTAG_GPP can detect broad panels of pathogens simultaneously.
We performed a field test with a total number of 347 stool samples from adult hospitalized patients that were
tested with the Luminex xTAG GPP assay; of the 157 samples positively tested for at least one pathogen by xTAG
GPP a total number of 30 samples was retested with the ProGastro SSCS assay. Assays were compared to standard
routine diagnostics.
Findings: Multiplexing significantly reduced the time to the initial identification of a pathogen. Moreover,
multiplexing detected pathogens for which a diagnostic assays was not requested by the physician and thus may
be an important tool for avoiding nosocomial outbreaks.
Conclusion: This first frontline approach with these assays approves their utility compared to conventional
microbiological methods.Short-form paper
Nosocomial gastrointestinal infections remain a major
health care problem worldwide, can be caused by bacte-
rial, viral, or parasitic pathogens, and require rapid diag-
nostic identification in order to avoid further spreading,
both for medical and economic reasons (Greig & Lee
2012; Vonberg et al. 2008; MacCannell et al. 2011; Zingg
et al. 2005). In daily practice, the interaction of different
medical disciplines (Virology, Microbiology, and Parasi-
tology), and the combination of conventional microbio-
logical methods with molecular assays can cause delays
in identification of gastrointestinal pathogens, thereby
hindering efficient counteractions (Mauch et al. 2009).
For rapid identification of the pathogens that may cause
nosocomial outbreaks a rapid multiplex front line
screening assay is highly desirable and would be helpful
in infection control (Khamrin et al. 2011). In the case of* Correspondence: schildgeno@kliniken-koeln.de
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in any medium, provided the original work is pC. difficile infections a rapid identification may not only
reduces nosocomial transmission but favor the clinical
outcome by initiating more timely a specific therapy
(Cohen et al. 2010).
Recently, two novel assays were launched to the market
which have the potential to speed up the initial pathogen
identification, namely the xTAG Gastrointestinal Pathogen
Panel (xTAG GPP) developed by Luminex (Luminex Mo-
lecular Diagnostics, Toronto, Canada), and the ProGastro
SSCS assay by Gen-Probe (Gen-Probe Incorporated, San
Diego, USA). The xTAG GPP is able to identify 15 patho-
gens; these are: Adenovirus 40/41, Campylobacter, Clostri-
dium difficile, Cryptosporidium, Entamoeba histolytica,
Enterotoxigenic Escherichia coli (ETEC), E. coli O157,
Shiga-like Toxin producing E. coli (STEC), Shigella, Sal-
monella, Giardia, Norovirus GI/GII, Rotavirus A, Vibrio
cholerae and Yersinia enterocolitica (Malecki et al. 2012),
whilst the ProGastro SSCS assay by Gen-Probe (Gen-Probe
Incorporated, San Diego, USA) is able to differentiate
between Salmonella, Shigella, Campylobacter (C. jejuni
and C. coli only) and Shiga Toxin-producing Escherichia
coli (STEC).n Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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order to get a first impression of their utility com-
pared to a “classical” diagnostic algorithm as asked for
by the physician (Bacteria: culture methods, Rota-,
Adeno- Norovirus: ELISA, Parasites: microscopy, C.
difficile Glutamat-Dehydrogenase-ELISA followed by toxin
ELISA and culture in cases ELISA was tested negative).
Stool samples were collected routinely and simultaneously
sent to the Microbiology/Virology laboratory and to our
laboratory where the multiplexing and real-time platforms
were located. A total number of 347 stool samples from
adult hospitalized patients was tested with the Luminex
xTAG GPP assay; of the 157 samples positively tested for
at least one pathogen by xTAG GPP a total number of
30 samples was retested with the ProGastro SSCS assay;
all samples were routinely screened for gastrointestinal
pathogens according the physicians’ requests, which does
not necessarily mean that the full pathogen panel available
in the xTAG GPP assay was tested by classical methods.
Stool samples were pretreated as requested by the
manufacturer’s protocols and subject to nucleic acid ex-
traction by using the Qiagen stool kit (Qiagen, Hilden,
Germany) automated on the QiaCube platform. The
eluates were subjected to PCR reactions as recom-
mended both by the ProGastro_SSCS and xTAG_GPP
assay manufacturers and were processed further on the
Rotorgene platform (ProGastro SSCS) or the Luminex
machine (xTAG GPP).
In detail, pretreatment for the xTAG GPP and ProGastro
SSCS assay using the NucliSENS easyMAG lysis Buffer
was performed as follows: 1 mL of NucliSENS easyMAG
Lysis Buffer (bioMérieux, Nürtingen, Germany), 10 μL
of E. coli phage MS2 (Luminex Molecular Diagnostics,
Toronto, Canada) for the xTAG GPP or 10 μL of Gastro
RNA/DNA Internal Control (GIC) (Gen-Probe Prodesse,
Waukesha, USA) for the ProGastro SSCS assay and ap-
proximately 100 to 150 μg of stool were added to Precelllys
Glas/Keramik-KIT SK38 (PEQLAB Biotechnologie GmbH,
Erlangen, Germany) bead tubes. The tubes were vortexed
by using the MagNA Lyser instrument (Roche Diagnostics
Deutschland GmbH, Mannheim, Germany) at 5000 rpm
for homogenization of the tissue. After 10 minutes incu-
bation time the SK38 (PEQLAB Biotechnologie GmbH,
Erlangen, Germany) tubes were centrifuged at 14,000 rpm
for two minutes at room temperature (RT) using the Mi-
crocentrifuge 5424 (Eppendorf AG, Hamburg, Germany).
200 μL of the supernatant were used for the extraction.
For ProGastro SSCS assays, ParaPak Culture & Sensitiv-
ity (PP) medium were used for pretreatment as follows:
500 μL of PP medium (Meridian Bioscience, Cincinnati,
USA) were introduced into a 1.5 mL tube and 10 μL of
the prepared GIC (Gen-Probe Prodesse, Waukesha, USA)
were added. The GIC was prepared according to the man-
ufactures instructions. Approximately 100 to 150 μg ofstool samples were inserted and the mixture was vortexed
for 1 minute. After a short centrifugation at RT 200 μL of
the supernatant were used for the extraction. Extraction
of DNA from stool samples was performed by using the
QIAamp MinElute Virus Spin Kit (Qiagen, Hilden,
Germany) for the QIAcube system according to the man-
ufacturer’s instructions. The eluate was stored at −80°C
until usage.
Pathogen detection was performed with the xTAG
Gastrointestinal Pathogen Panel and the ProGastro SSCS
assay as follows: xTAG OneStep RT-PCR Buffer 5X,
xTAG RNase-free water, xTAG BSA were thawed at
RT and afterwards kept on ice for the Mastermix (MM).
2.5 μL xTAG RNase-free water, 7.5 μL xTAG OneStep
Buffer 5X and 0.5 μL xTAG BSA (10 mg/mL) were
added to the MM for each PCR reaction. The xTAG
GPP Primer Mix as well as the xTAG OneStep Enzyme
Mix were thawed and kept on ice during the preparation
of the MM. 2.5 μL of Primer Mix as well as 2.0 μL of
the Enzyme Mix were added to the MM for each PCR
reaction. All reagents were vortexed and briefly cen-
trifuged before use. The volume for one extra reaction
was included for ≤ 10 samples, and the volume for two
extra reactions were included for more than 10 samples
to compensate pipetting variability.
10 μL of the extraction product were mixed with 15 μL
of MM in a 0.2 mL thin-walled PCR-tube for a total RT-
PCR reaction volume of 25 μL. The negative control
contained 10 μL xTAG RNase-free water instead of the
extraction product. No extra positive controls were in-
cluded besides the internal MS2 control.
The PCR tubes were placed in a thermal cycler preheated
to 53°C. Four stages were used for the RT-PCR program:
The first was 1 cycle at 53°C for 20 min followed by 1 cycle
at 95°C for 15 min as the second stage to ensure proper
denaturation. Amplification was achieved in the third stage
starting at denaturation temperature of 95°C for 30 sec,
followed by annealing at 58°C for 30 sec and elongation at
72°C for 30 sec repeated 38 times. This temperature was
held in the last stage for 2 min as a final elongation. When
the program finished the temperature was set and hold at
4°C at which all samples were stored after RT-PCR.
The xTAG GPP Bead Mix and the xTAG Reporter
Buffer were taken out of the refrigerator and brought to
RT in the dark. 20 μL of bead mix were aliquot into a
96-well microtitre plate and 5 μL of vortexed RT-PCR
product were added. After vortexing and a short centri-
fugation of the xTAG 0.22 SAPE, 1 μL was taken and di-
luted in a 2.0 mL tube with 74 μL of xTAG Reporter
Buffer for each sample. An additional reaction volume of
xTAG 0.22 SAPE and xTAG Reporter Buffer was added
for ≤ 10 samples or two additional reaction volumes for
more than 10 samples. 75 μL reporter solution were
then pipetted in each microtritre well containing 25 μL
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100 μL per hybridization reaction. The plate was covered
with microseal film and placed in the thermal cycler
preheated to 60°C. This was the temperature the pro-
gram was started at for 3 min, followed by 45 min at
45°C. The temperature was hold at 45°C at the end of
the program because the samples may not cool down
until analysis which was proceeded directly after the
hybridization. The Luminex 100/200 (Luminex Molecu-
lar Diagnostics, Toronto, Canada) was used with the
TDAS GPP software 1.00. The instrument was started at
least 20 min before the hybridization was finished to
heat up the laser and the Luminex XYP heater block
was set to 45°C prior at least 10 min to analysis to pre-
vent prolonged hybridization times. After hybridization
the microseal film was removed from the microtitre
plate and the plate was inserted into the heater block.
The xTAG GPP protocol was used for each batch and
the data produced were analyzed by the xTAG Data
Analysis Software (TDAS).
For the ProGastro SSCS assay 0.2 mL thin-walled PCR
tubes (Qiagen, Hilden, Germany) were used for setting
up the PCR reactions. The volume for the PCR reaction
was 25 μL containing 5 μL nucleic acid of the samples
or positive controls (Salmonella, Shigella, C. jejuni, Shiga
Toxin producing E. coli (SSCSpc) and C. coli) and 20 μL
of SSC or STEC mix, respectively. A positive matrix con-
trol was not included. The negative control prepared for
the quantification step consisted of 5 μL molecular grade
water and 20 μL SSC or STEC mix, respectively. All
tubes were kept on ice during the preparation for the
PCR. A short description of the SSC and STEC mixes
can be found in Table 1.
The Rotor-Gene Q system (Qiagen, Hilden, Germany)
was used to carry out the Real Time PCR analysis. A 36-
Well rotor was used to take up a maximum of 36 thin-
walled 0.2 mL PCR tubes. The amplification process
consisted out of three different cycling stages. In the first
the temperature was 95°C for 600 secs with shut down op-
tics to ensure a proper and complete denaturation of the
nucleic acid. This stage was not repeated. The second stage
started with a denaturation temperature of 95°C for 30 secs
and proceeded to an annealing/elongation temperature ofTable 1 Comparison of results acquired by using the xTAG GP




Test was not requested
by physician
positive samples




104 data sets were either confirmed by both tests, were not performed with a defa
When the tests were not matching further differentiation was achieved by showing
or if both laboratories produced positive but not matching results.55°C for 60 secs. It was repeated five times and the optics
were shut off. The last stages consisted of 40 cycles starting
with a denaturation temperature of 95°C for 10 secs with
shut off optics and an annealing/elongation temperature of
55°C for 60 secs with running optics.
Four different optical channels were used for detecting
the presence of target genes according to the manufac-
turer: FAM, TET, TxR and Cy5. These channels were
named green, yellow, orange and red by the Rotor-Gene
Q software (Rotor-Gene 2.0.2.4), respectively.
The thresholds for the ct values were set and analyzed
manually for each channel that was measured. The re-
sults were compared to the outcomes of the previously
test with the xTAG GPP performed with the Luminex
100/200 system.
With the xTAG GPP assay 347 samples were tested
and 157 were positive for one or more pathogenic or-
ganisms. Norovirus GI/GII caused 82 infections which
accounts for 52% of all positive samples. The second
most abundant organism detected was toxigenic C. diffi-
cile. In 47 cases both toxins (A and B) were detected, in 11
cases only toxin A, in one case only toxin B. Infections
with Campylobacter were observed 8 times, infections
with Salmonella and Rotavirus A were detected 4 times
for each of the organisms. In 3 cases Cryptosporidium was
detected, Shigella, Enterotoxigenic E. coli, Shiga-like toxin-
producing E. coli and Giardia lamblia were all detected
once. In one case a double infection with Rotavirus A and
toxigenic C. difficile occurred and was confirmed by tests
with the conventional methods (ELISA). Other double in-
fections that were observed included 4 times Norovirus
GI/GII with toxigenic C. difficile, one time Norovirus GI/
GII with Salmonella and one time Salmonella with Giar-
dia lamblia, but these cases could not be confirmed by
conventional methods (culture methods for Salmonella,
ELISA and PCR for Norovirus and microscopy for Giar-
dia). For one double infection with Campylobacter and
Norovirus GI/GII only the presence of Campylobacter was
confirmed by culture, but not Norovirus GI/GII.
Of the total sample cohort it was possible to compare
the xTAG GPP to the conventional diagnostic tech-
niques used by our external microbiology lab to screen
for diarrheal pathogens in 104 cases for which fullP or conventional techniques
red to results of conventional methods
repancies because of positive results
roduced by conventional methods
different positive results for
both test methods
7 2
ult test as it was not marked at the requisition form or were inconsistent.
if the positive result was produced by the xTAG GPP, a conventional method
Table 3 Comparison of ProGastro SCCS with xTAG GPP
Assays
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GPP detected a pathogen that was not being tested for
by the conventional method as the physician who re-
quested the diagnostics did not mark the respective test
in the requisition form (Table 1). In 70 cases the results
of the xTAG GPP were confirmed by the respective con-
ventional method. However there were 15 discrepancies
which were further differentiated into 6 positively tested
samples by the xTAG GPP that were negatively tested by
conventional methods as well as 7 positively tested sam-
ples by conventional methods that did not produce posi-
tive signals by the xTAG GPP. Furthermore in two cases
the pathogens that were displayed were completely dif-
ferent, namely in one case ELISA detected Norovirus
whilst xTAG GPP detected C. difficile, and in the other
case C. difficile was detected by conventional methods
whilst xTAG GPP detected rotavirus. All C. difficile posi-
tive samples that were detected by conventional methods
were also confirmed by either a positive C. difficile cul-
ture test or by a C. difficile toxin ELISA.
Discordant results were in detail (Table 2): A Norovirus
infection was observed for the first two samples (A and B)
followed by double infections with Norovirus and C. difficile
in samples C and D by the conventional techniques (Bauer
et al. 2009), i.e. ELISA for Norovirus and culturing for
C. difficile; none of these results (A-D) was confirmed by
xTAG GPP. Single pathogens were detected by conven-
tional culturing in samples E and F, C. difficile and Yersinia,Table 2 Detected pathogens that were either detected
only by xTAG GPP or by the conventional methods
Sample Results of the xTAG GPP Results of conventional
methods
A negative Norovirus GI/GII
B negative Norovirus GI/GII
C negative Norovirus GI/GII + C. difficile
D negative Norovirus GI/GII + C. difficile
E negative C. difficile
F negative Yersinia
G Norovirus GI/GII negative
H Norovirus GI/GII negative
I C. difficile negative
J Shigella negative
K Stx2 negative
L Norovirus GI/GII +
Campylobacter
Campylobacter
M Campylobacter Norovirus GI/GII +
Campylobacter
N C. difficile Norovirus GI/GII + C. difficile
In case of sample L and in samples M and N double infections were found by
the xTAG GPP and the conventional methods, respectively, instead of a single
infection which was observed for the opposing test.respectively (Table 2). The following samples G to K did
not produce positive signals during conventional tests. The
xTAG GPP detected Norovirus GI/GII in samples G and H,
C. difficile in sample I, Shigella in J and Stx2 in sample K.
Moreover, 29 samples previously tested positive by the
xTAG GPP were retested by the ProGastro SSCS method.
Except two differences ProGastro SSCS confirmed the
xTAG GPP results: In one case, xTAG GPP detected
Shigalike-toxin 1 gene which was not found by the Pro-
GastroSSC, in the other case xTAG GPP detected Shigella
which was detected neither by culturing nor the Pro-
GastroSSC assay. The results are summarized in Table 3.
Most strikingly, the turnover time from sampling to





13 Stx2 E. coli O157, Stx2
14 Stx1/Stx2 Stx1/Stx2
15 Campylobacter Campylobacter
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using the xTAG GPP assay was 1 day, ranging from 0.5
days to a maximum of 2 days except one sample that
was lost for several days due to a mail transportation
error, whilst the median turnover time for the classical
diagnostic algorithm was 3 days (Figure 1), which was
highly significant with a p-value of p = 0.0000021
resulting from the one-sided T-test for paired samples
and a p-value of p = 0.0000042 for the two-sided T-test.
The major bias of our study is that only a limited
number of samples positive for the respective pathogens
was tested and that for some pathogens like Giardia not
a single positive sample was available. However, despite
these limitations the study shows that the turnover time
from sampling to the first result may be significantly re-
duced provided future studies with larger patient cohorts
could confirm our present results.
In summary, provided that optimal transport and lab
logistics are established, both assays can lead to a result
from sampling to pathogen identification within 6–10








































Figure 1 Time needed from receiving a sample to communicate the d
were compared to the corresponding samples that were tested with conve
green, conventional: red) was drawn in the diagram.more specific therapy, setup rapid and efficient hygiene
counteractions or, vice versa, to de-isolate patients and
thus save economic resources due to false or unnecessary
blockades of hospital beds. For the decision to de-isolate
patients dependent on a negative result of a multiplex-PCR
test, negative predictive values are needed in future. For
some bacterial pathogens with the ability of differing anti-
biotic susceptibilities culture methods will be needed in
addition. Finally, although it might be to early for this
conclusion, it is worth to restructure guidelines for the
diagnostic and treatment procedures of gastrointestinal in-
fections that take into account the advantages of early
multiplexing technology. It can be concluded multiplexing
in gastrointestinal infection diagnostics has the potential to
(a) reduce the time to the first identification of a pathogen,
may (b) influence subsequent clinical courses by earlier
start of specific treatments and diagnostical procedures
and avoid false isolations (which in turn is a significant
economic factor), and may (c) reduce the number of false
negative diagnostics due to missing assays that were not
requested after the first round of sampling.Conventional
iagnostic findings. The 104 samples handled with the xTAG GPP
ntional methods. For reasons of comparability the median (xTAG GPP:
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